HCA029 recognises Osteocalcin (Bone Gla Protein), a 49 amino acid single chain vitamin K dependent protein (MW 5.8 kDa), made by osteoblasts and a major component of the non-collagenous bone matrix. Post-translational modification by a vitamin K dependent carboxylase produces three g-carboxyglutamic acid residues at positions 17, 21 and 24, giving it a high affinity for calcium. The mature protein contains a single intrachain disulfide bond joining Cys23 to Cys29. The secondary structure is highly calcium dependent and contains 14% a-helix, 20% ß-sheet and 67% random form in the presence of calcium, and 1% a-helix, 20% ß-sheet and 79% random form in the ab-sence of calcium, seeDelmas PDet al.for details. Sixty to ninety percent of de novo synthesized osteocalcin is incorporated into the bone matrix where it binds to hydroxy-apatite during matrix mineralization. The remainder of the osteocalcin is released into the circulation where it can be measured as a sensitive marker of bone formation. Serum osteocalcin is elevated in diseases characterized by increased bone turnover such as os-teoporosis, hyperparathyroidism and Paget’s disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency, seeLee, A.J.et al.for details. Circulating Osteocalcin is unstable as it contains a tryptic cleavage site at amino acids 43-45 near the C-terminus. After cleavage a large fragment containing amino acids 1 – 43 is formed, which contains both the N-terminus and the middle portion of the protein. Whereas the levels of intact Osteocalcin rapidly decreases, 1-43 Osteocalcin remains stable in serum even after repeated freeze thaw cycles or storage at elevated temperatures, seeLee, A.J.et al.for details.
HCA recognises intact Osteocalcin but not fragments corresponding to amino acids 7-19, 37-49 or 45-49.
Species Cross-Reactivity
Target Species
Cross Reactivity
Human
Yes
Product Form
A bivalent human recombinant Fab selected from the HuCAL® GOLD phage display library. Expressed in E. coli and purified using NiNTA affinity chromatography. This Fab fragment is dimerized via a helix-turn-helix motif. The antibody is tagged with a myc-tag (EQKLISEEDL) and a his-tag (HHHHHH) at the C-terminus of the anti-body heavy chain. - Lyophilised
Application
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visitwww.abdserotec.com/protocols.
Application Name
Yes
No
Not Determined
Suggested Dilution
ELISA
2ug/ml
Western Blotting
5ug/ml
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
6 months from date of reconstitution.
Licensed Use
For in vitro research purposes only, unless otherwise specified in writing by AbD Serotec.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
